Kimberly A. Brown, MD, and Zobair M. Younossi, MD, MPH, FACG
This program is sponsored by Madrigal Pharmaceuticals, Inc.
This session will explore several emerging concepts in NASH including: (1) epidemiology and comorbidities, (2) pathophysiology and the role of lipotoxicity in the liver, (3) morbidity and mortality, (4) patient identification and monitoring approaches, and (5) disease management strategies.
Open to all in-person ACG 2023 attendees, industry-sponsored product theater events provide additional educational opportunities. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibitor Product Theater presentations.
